T-cell lymphomas are a heterogeneous group of diseases but are uniformly aggressive and respond poorly to our conventional chemotherapy, with the notable exception of ALK-positive anaplastic large cell lymphoma. Here, ALK is linked to anaplastic large cell lymphoma.